CDK4/6 inhibition induces a senescence-associated secretory phenotype via delayed NF-κB activation
Authors:
- Joanna Lan-Hing YeungJYJoanna Lan-Hing Yeung
- Justin RendlemanJRJustin Rendleman
- Lauren Anderson WestcottLWLauren Anderson Westcott
- Arnold OuAOArnold Ou
- Matthew PresslerMPMatthew Pressler
- Nicole PaganeNPNicole Pagane
- Irene DubaIDIrene Duba
- Ria HosuruRHRia Hosuru
- Bat-Ider TumenbayarBTBat-Ider Tumenbayar
- Viviana I RiscaVRViviana I Risca
Open Access
- 9 July 2026
- journal article
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 9 (9) , e202603790
Abstract
Cellular senescence consists of regulated phenotypes associated with permanent exit from the cell cycle in response to stressors such as genomic instability. The consequences of senescence go beyond individual cells because of the senescence-associated secretory phenotype (SASP), which can induce inflammation in neighboring cells. Some cancers respond to CDK4/6 inhibitors (CDK4/6i) with a senescence-like phenotype in the absence of extensive DNA damage. We asked how the SASP and the transcriptional regulatory profile triggered by CDK4/6i-driven arrest compare with the canonical NF-κB–regulated SASP triggered by DNA damage. We profiled the dynamics of transcriptional regulation in response to the CDK4/6i, palbociclib, and the DNA-damaging agent, doxorubicin. We found that up-regulation of NF-κB–driven SASP genes was shared across both drugs, although delayed in CDK4/6i, coinciding with slower enhancer activation and epigenetic changes. ATM/ATR inhibition did not affect CDK4/6i-induced NF-κB nuclear localization, suggesting an alternative upstream activator. Inhibiting NF-κB suppressed the expression of SASP genes without reversing stable arrest, pointing to SASP manipulation as a potential therapeutic strategy and providing insights into controversies regarding cell cycle arrest–driven SASP.Keywords
Funding Information
- Rita Allen Foundation (Scholar Award S-2108-02147)
- Starr Cancer Consortium (I16-0058)
- V Foundation for Cancer Research (V2019-011)
- Monique Weill-Caulier Trust (Career Scientist Award)
- Kellen Women’s Entrepreneurship Fund (Grant)
- Natural Sciences and Engineering Research Council of Canada (Postgraduate Scholarship-Doctoral)
- American Cancer Society (PF-23-1034949-01-CCB)
- National Science Foundation (1946429)
This publication has 100 references indexed in Scilit:
- Molecular Dissection of Formation of Senescence-Associated Heterochromatin FociMolecular and Cellular Biology, 2007
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences of the United States of America, 2005
- Formation of MacroH2A-Containing Senescence-Associated Heterochromatin Foci and Senescence Driven by ASF1a and HIRADevelopmental Cell, 2005
- NF-κB and AP-1 Connection: Mechanism of NF-κB-Dependent Regulation of AP-1 ActivityMolecular and Cellular Biology, 2004
- Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular SenescenceCell, 2003
- ATM Mediates Phosphorylation at Multiple p53 Sites, Including Ser46, in Response to Ionizing RadiationJournal of Biological Chemistry, 2002
- DNA damage activates p53 through a phosphorylation–acetylation cascadeGenes & Development, 1998
- Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in VivoJournal of Biological Chemistry, 1997
- The Interleukin-1 Receptor Accessory Protein (IL-1RAcP) Is Essential for IL-1-induced Activation of Interleukin-1 Receptor-associated Kinase (IRAK) and Stress-activated Protein Kinases (SAP Kinases)Journal of Biological Chemistry, 1997
- NF-κB Activation by Interleukin-1 (IL-1) Requires an IL-1 Receptor-associated Protein Kinase ActivityJournal of Biological Chemistry, 1995